Alan secures €480 million to scale prevention-first healthcare
A €480 million Series G financing round has vaulted French health insurer Alan to a €5.5 billion valuation, signaling a market shift toward proactive medical care. Led by Dutch technology investor Prosus, the funding will fuel the company’s push to export its AI-integrated prevention model into new international markets.
The Paris-based company, which currently serves over 1.1 million members, intends to use the capital to deepen its footprint in France, Belgium, Spain, and Canada while aggressively expanding its global reach. By integrating insurance coverage with AI-powered health assistance and care navigation, Alan aims to dismantle the traditional reactive model of waiting for illness to manifest before intervening. The firm reported strong momentum heading into this expansion, citing over €800 million in annual recurring revenue and a 53% year-over-year growth rate as of the first quarter of 2026.
CEO Jean-Charles Samuelian-Werve emphasized that the partnership with Prosus provides the necessary expertise to scale their consumer-facing platform globally. For investors, the appeal lies in Alan’s ability to turn health management into a continuous, data-driven cycle rather than a transactional one. The financing remains subject to customary regulatory approvals, including oversight from French financial authorities, but positions the company to further invest in proprietary AI technology and potential strategic acquisitions.
Comments (0)
No comments yet. Be the first!